Last reviewed · How we verify
NCT05952999: HaH
Analysis of the Virtual Acute Care at Home Experience
trial testing Digital Care Solution as supportive personalized care in Conditions in 9,654 participants. Enrolling by invitation.
31 December 2026
Quick facts
| Lead sponsor | OSF Healthcare System |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 9,654 |
| Start date | 15 August 2023 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Digital Care Solution as supportive personalized care
- Traditional Hospital Level Care
Conditions studied
- Conditions — all drugs for Conditions →
- Infections — all drugs for Infections →
- Heart Failure — all drugs for Heart Failure →
- Renal and Urinary Disorders — all drugs for Renal and Urinary Disorders →
Sponsor
OSF Healthcare System — full company profile →
Who can join
18 and older, any sex, with Conditions or Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to examine the implementation, intervention effectiveness, and dissemination of a digital acute care delivery model for improving selected health outcomes in the Hospital at Home population.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Patient-Centered Care: A Qualitative Analysis of Patient and Caregiver Experiences in a Hospital at Home Program.
Dalstrom MD, Klein CJ, Rothrock-Magana M, Cooling M. · · 2025 · cited 1× · PMID 40464036 · DOI 10.1177/23743735251347706
Verify or expand the search:
- PubMed search for NCT05952999
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Conditions
Currently open trials in the same condition.
- NCT07524933 — Comparison of the Effectiveness of Nerve Hydrodissection With Saline Injection of 5% Dextrose in Carpal Tunnel Syndrome. · NA · active not recruiting
Other OSF Healthcare System trials
Trials by the same sponsor.
- NCT06470984 — Ethics Education to Support Nurse Leaders in HealthCare · NA · active not recruiting
- NCT05742191 — The Effect of Daylight Saving Time Transitions on Sleep and Migraine Headaches. · unknown
- NCT05555095 — Examining Digital Health Care Delivery Models Through Medicaid Collaborative · recruiting
- NCT04888000 — Interprofessional Group Intervention to Enhance Compassion Satisfaction and Resilience · NA · completed
- NCT04462796 — The Effect of Magnesium Citrate Supplementation in Restless Legs Syndrome (RLS) · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05952999 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by OSF Healthcare System
- Last refreshed: 17 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05952999.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing